provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
Duvyzat Coupon - Duvyzat 140ml of 8.86mg/ml bottle of oral suspension

Duvyzat

givinostat
Used for Muscular Dystrophy
Used for Muscular Dystrophy

Duvyzat (givinostat) is an FDA approved medication used to treat Duchenne Muscular Dystrophy (DMD) in people ages 6 years and older, regardless of the type of genetic mutation (change) they have. This medication doesn’t contain a steroid and isn’t an injection. Instead, it’s available as a liquid solution that’s taken 2 times a day by mouth. Common side effects are diarrhea, nausea, and stomach pain. During treatment, you’ll work with your child's care team to regularly check labs, such as blood counts and triglyceride levels. These tests are important because they help monitor for potential issues that could lead to side effects, like excessive bleeding.

Reviewed by:
reviewer
Kaleigh Taylor, PharmD Candidate
reviewer
Daisy Chau, PharmD
reviewer
Connie Zheng, PharmD
Last reviewed on July 23, 2024
BasicsSide effectsPros & consPharmacist tipsFAQsWarningsDosageCostAlternativesImagesReferencesPricesMedicare
basics-icon

What is Duvyzat (givinostat)?

What is Duvyzat (givinostat) used for?

How Duvyzat (givinostat) works

Duvyzat (givinostat) is a histone deacetylase inhibitor, which means it blocks a protein called histone deacetylase from working. People with DMD are thought to have higher histone deacetylase activity in their weakening muscles. By blocking these proteins, Duvyzat (givinostat) helps muscles rebuild and reduces inflammation.

Drug Facts

Common BrandsDuvyzat
Drug ClassHistone deacetylase inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
coupon-save-icon

Get your GoodRx coupon

Avg retail price
$00
GoodRx discount
$37689.70
See prices
basics-icon

What are the side effects of Duvyzat (givinostat)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Other Side Effects

  • Muscle Pain
  • Rash
  • Pain in joints
  • Constipation
  • Tiredness
  • Smaller appetite

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Serious Bleeding: nosebleeds, excessive bleeding, unusual bleeding, blood in stool, tiredness
  • Abnormal heart rhythm: heart pounding, dizziness, lightheadedness, passing out
  • Severe diarrhea and vomiting: headache, increased thirst, dark-yellow urine, severe stomach pains

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Duvyzat (givinostat)

thumbs-up

Pros

Is a liquid medication which can be easier for your child to take

Is flavored (peach-cream) which may allow your child to enjoy the taste without spitting it out

Doesn’t need to be stored in the refrigerator

Can be used in all genetic variations of DMD making it more accessible

thumbs-down

Cons

Requires regular blood work to test for blood cell counts and triglyceride levels

Your child needs to take it twice a day

Can cause stomach side effects like diarrhea, nausea, and vomiting

Needs to be taken with food

pharmacist-tips

Pharmacist tips for Duvyzat (givinostat)

pharmacist

  • Before you measure a dose of Duvyzat (givinostat), turn the medication bottle upside down and shake well for at least 30 seconds until the liquid is an even mixture throughout. This makes sure that your child receives the correct dose of medication.

    • Only use the oral syringe that comes with Duvyzat (givinostat) to measure your child’s dose to make sure it’s accurate. If your child's dose is more than 5 mL, you will have to measure two separate times to give the full dose using the same syringe.

      • Don’t throw away the syringe. After each use, wash the syringe with water and allow it to air dry. The syringe that comes with Duvyzat (givinostat) is designed to fit in the hole on top of the bottle.

        • If your child missed a dose of Duvyzat (givinostat), go ahead and skip that dose and return to your normal schedule. Don’t give two doses of Duvyzat (givinostat) at one time since that can put your child at a greater risk of experiencing side effects.

          • Give Duvyzat (givinostat) with food to help the body absorb more of the medication so it can work better. However, don't mix Duvyzat (givinostat) with other liquids or water.

            • Duvyzat (givinostat) is good only for 60 days after opening. Write the date you opened Duvyzat (givinostat) directly on the bottle to help you remember. Throw away any medication that wasn’t used by the 60 days expiration.

              • Store Duvyzat (givinostat) at room temperature, don’t store it in the refrigerator so the medication doesn't go bad.

                • Create a calendar to help organize the many appointments for blood work while taking Duvyzat (givinostat). These appointments help to make sure that the medication continues to be safe for your child.

                  • Duvyzat (givinostat) commonly causes diarrhea and nausea. To avoid dehydration, be sure that your child drinks enough fluids while taking this medication.

                    • Duvyzat (givinostat) can interact with a lot of medications, and some combinations can dangerously affect your heart rhythm. So be sure to communicate what medications your child is taking to their care team, even if it’s over the counter, to make sure that Duvyzat (givinostat) is safe to use.

                      faqs

                      Frequently asked questions about Duvyzat (givinostat)

                      What is Duchenne Muscular Dystrophy (DMD)?
                      Duchenne Muscular Dystrophy is a genetic condition passed from parent to child that causes muscle damage and muscle weakness over time. This condition affects more boys compared to girls. Symptoms begin to show up between ages 2 and 3 years old. Common signs and symptoms are toe walking, difficult running and falling down. This condition continues to get worse over time but can be treated with Duvyzat (givinostat) to slow down the muscle loss over time.
                      Can anyone with DMD take Duvyzat (givinostat)?
                      Duvyzat (givinostat) is only approved to slow muscle loss in DMD for people ages 6 years and older. Since children are typically diagnosed with DMD around 2-5 years old, this medication might not be an option right away. Instead, steroids are usually started as a first-choice treatment to slow muscle breakdown. Duvyzat (givinostat) is approved to treat all types of DMD, which can be caused by different genetic changes (or mutations). Other approved medications, like Vyondys 53 (golodirsen), only work for people with a specific genetic mutation. Talk to your prescriber to see if Duvyzat (givinostat) is right for your child.
                      How do you give Duvyzat (givinostat) to a child?
                      Shake the bottle of Duvyzat (givinostat) and measure the correct dose with the provided syringe. Make your child sit upright and place the top of the syringe against the inside of their cheek. Push the plunger of the syringe slowly until all the medication is out. If your child’s dose is more than 5mL, measure the remainder of the medication and do the same steps again.
                      Is Duvyzat (givinostat) a steroid medication ?
                      No. Duvyzat (givinostat) is a histone deacetylase blocker. This medication doesn’t contain any steroid components. Other DMD medications, like Emflaza (deflazacort), are steroids which is typically a first-choice treatment for DMD. Because Duvyzat (givinostat) is pretty new, it isn’t listed on the current guidelines for treatment of DMD yet. This can be discussed with your child's prescriber to determine if this medication is appropriate.
                      Does Duvyzat (givinostat) cure Duchenne Muscular Dystrophy?
                      No. Duvyzat (givinostat) doesn’t cure Duchenne Muscular Dystrophy. Duvyzat (givinostat) is a medication that helps restore muscle and prevent muscle loss. Currently, there isn’t a cure for DMD. But Duvyzat (givinostat) helps to slow the worsening of DMD. If you have any questions about whether this medication is appropriate for your child, reach out to their prescriber.
                      How well does Duvyzat (givinostat) work?
                      Duvyzat (givinostat) works to slow down muscle damage over time. A study involving young boys with DMD compared results of a 4 stair climb between a group that received Duvyzat (givinostat) with corticosteroids with a group that took corticosteroids with a placebo. Boys in both treatment groups receive corticosteroids as this is a typical first-choice treatment in children with DMD. The study measured how quickly the boys could climb 4 stairs, both before starting treatment and again 18 months later. At the end of the study both groups showed worsening in their ability to climb the 4 stairs. But, the group of boys that received Duvyzat (givinostat) had a slower decline compared to the group that only received corticosteroids.
                      Questions: What do I do to help with diarrhea or nausea and vomiting with Duvyzat (givinostat)?
                      Answers: If your child is experiencing severe diarrhea or nausea and vomiting, contact your child’s care team. It’s important to make sure that your child is drinking plenty of fluids to avoid dehydration. Start giving smaller meals throughout the day. Slowly give more fiber rich foods like oats, broccoli, and whole grains. If appropriate, there are certain medications your child’s care team may suggest for diarrhea or nausea and vomiting. Depending on how serious the side effects are, your child’s prescriber may also adjust the dose for Duvyzat (givinostat) or recommend stopping the medication altogether.
                      GoodRxEducationalIcon

                      How to save using GoodRx

                      Compare Prices
                      1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                      Select your free coupon
                      2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                      Show coupon to your pharmacist
                      3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                      Get free couponLearn more
                      warings-icon

                      What are the risks and warnings for Duvyzat (givinostat)?

                      Duvyzat (givinostat) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                      risk-warning

                      Low blood cell counts

                      • Risk factors: RF 1 | RF 2

                        Taking Duvyzat (givinostat) can cause lower blood cell counts, particularly lower platelet levels. These levels drop to their lowest during the first two months of treatment, and continue to stay low as long as your child takes this medication. This is why your child will have their labs drawn every two weeks for the first 2 months, then monthly for the next 3 months, and eventually every 3 months after that while continuing treatment. These labs are important to make sure that the dose of Duvyzat (givinostat) continues to be safe for your child. Labs are completed to catch low platelet counts before they get dangerously low, which can lead to issues such as bleeding or increased risk for infections.

                        If your child has lower platelet counts, their prescriber may lower the dose of Duvyzat (givinostat) or temporarily stop the medication. If it still doesn’t get better, your child may have to stop taking the medication permanently. Be sure to look out for symptoms and contact your child’s prescriber if they experience unusual bruising, nosebleeds, or any type of excessive bleeding.

                        risk-warning

                        High triglyceride levels

                        Taking Duvyzat (givinostat) can raise fat levels in the blood. Having high triglycerides levels over time can increase the chances of heart disease. Your child should get their triglyceride labs checked during their 1st month, 3rd month, and 6th month of starting treatment, and then every 6 months after that. Because there usually aren’t any symptoms with having high triglycerides, it’s important for your child to go to their lab appointments. If your child has high triglycerides, their care team might lower their Duvyzat (givinostat) dose. A balanced diet with bland proteins, carbs, healthy fats, and fiber is important for people with DMD and can help keep triglycerides low.

                        risk-warning

                        Stomach problems

                        Diarrhea, nausea, and vomiting are common side effects of Duvyzat (givinostat). Children are more likely to experience diarrhea within the first few weeks of treatment, and nausea and vomiting within the first 2 months of treatment. Contact your child’s care team if they have severe diarrhea, nausea, or vomiting after taking Duvyzat (givinostat). Your child’s care team may recommend other medications, such as ondansetron (Zofran) or loperamide (Imodium A-D), that can help ease symptoms If symptoms become severe, your child’s prescriber might suggest reducing the dose or stopping the medication. It’s also important to make sure that your child is getting enough fluids to prevent dehydration. At home you can help by providing smaller meals throughout the day which may help relieve symptoms.

                        risk-warning

                        Abnormal heart rhythm

                        • Risk factors: Use of other medications that cause abnormal heart rhythm | Coronary artery disease | Electrolyte imbalance

                          Duvyzat (givinostat) can cause a potentially life-threatening abnormal heart rhythm known as QT prolongation. Your child might need an electrocardiogram (ECG or EKG) before starting the medication if they have a history of heart problems or are taking another medication that may cause QT prolongation. Sometimes QT prolongation doesn’t cause any noticeable symptoms unless it becomes more serious. Serious symptoms may include heart pounding, unusual dizziness, or passing out. It’s important to contact your child's care team right away if they experience any of those symptoms as Duvyzat (givinostat) may need to be stopped.

                          dosage

                          Duvyzat (givinostat) dosage forms

                          The average cost for 1 bottle of 140ml of 8.86mg/ml of Duvyzat (givinostat) is $37689.70 with a free GoodRx coupon.0
                          bottle of oral suspension
                          Bottle of oral suspension
                          DosageQuantityPrice as low asPrice per unit
                          140ml of 8.86mg/ml 1 bottle$37689.70$37689.70

                          Typical dosing for Duvyzat (givinostat)

                          Duvyzat (givinostat) is approved for people ages 6 years and older.

                          Duvyzat (givinostat) comes as an oral solution that contains 8.86 mg per mL.

                          Your child's dose will depend on their weight:

                          • 10kg to less than 20kg: The typical dose is 22.2 mg (2.5 mL) twice daily by mouth.

                          • 20kg to less than 40kg: The typical dose is 31 mg (3.5 mL) twice daily by mouth.

                          • 40kg to less than 60kg: The typical dose is 44.3 mg (5 mL) twice daily by mouth.

                          • 60kg or more: The typical dose is 53.2 mg (6 mL) twice daily by mouth.

                          The dose might be different if your child is experiencing side effects like severe diarrhea, low blood counts, and high triglycerides levels in the blood.

                          drug-cost

                          How much does Duvyzat (givinostat) cost?

                          To access savings, use a GoodRx coupon and pay just a fraction of the retail price.
                          Duvyzat (brand)
                          GoodRx lowest price

                          $37689.70

                          0
                          View prices & coupons
                          alternatives

                          What are alternatives to Duvyzat (givinostat)?

                          There are a number of medications that your doctor can prescribe in place of Duvyzat (givinostat). Compare a few possible alternatives below.
                          Duvyzat (givinostat)
                          Used for:
                          $37689.70 Lowest GoodRx priceView Prices
                          Emflaza (deflazacort)
                          Used for:

                          • Duchenne muscular dystrophy (DMD) in people 2 years and older

                          $4153.72 Lowest GoodRx priceView Prices
                          Vyondys 53 (golodirsen)
                          Used for:

                          • Treatment of Duchenne Muscular Dystrophy (DMD) in people with a specific genetic mutation

                          View Prices
                          images

                          Duvyzat (givinostat) images

                          pink - Duvyzat 8.86mg / mL Suspension
                          This medicine is Pink Bottle Of Oral Suspension.pink - Duvyzat 8.86mg / mL Suspension

                          Get savings updates for Duvyzat (givinostat)

                          Receive price alerts, news, and other messages from GoodRx about Duvyzat (givinostat) and other healthcare topics and relevant savings offers.

                          By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                          References

                          Best studies we found

                          Bajanca, F., et al. (2017). Epigenetic regulators modulate muscle damage in duchenne muscular dystrophy model. Public Library of Science Currents.

                          Birnkrant, D. J., et al. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurology.

                          Centers for Disease Control and Prevention. (n.d.). Protect your child: Use the right tool to give the right dose.

                          View All References (10)

                          Consalvi, S., et al. (2011). Histone deacetylase inhibitors in the treatment of muscular dystrophies: Epigenetic drugs for genetic diseases. Molecular Medicine.

                          Cure Duchenne. (n.d.). What is nutrition?

                          Farzam, K., et al. (2023). QT prolonging drugs. StatPearls.

                          Italfarmaco SPA. (2024). Duvyzat- givinostat suspension [package insert]. DailyMed.

                          Mercuri, E., et al. (2024). Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Neurology.

                          Muscular Dystrophy Association. (n.d.). Duchenne muscular dystrophy (DMD).

                          Parent Project Muscular Dystrophy. (n.d.). Diagnosis & early ambulatory (childhood).

                          Sandonà, M., et al. (2023). Histone deacetylases: Molecular mechanisms and therapeutic implications for muscular dystrophies. International Journal of Molecular Sciences.

                          U.S. Food and Drug Administration. (2024). FDA approves nonsteroidal treatment for Duchenne muscular dystrophy.

                          Venugopal, V., et al. (2023). Duchenne muscular dystrophy. StatPearls.

                          GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                          Was this page helpful?

                          Browse medications

                          View All

                          Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.